← Feed

WILSON TROY EDWARD

SEC Form 4 insider
President and CEO · Kura Oncology, Inc. ($KURA)
1 thesis · first seen Aug 17, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$KURASEC Form 4bullish
WILSON TROY EDWARD · President and CEO at Kura Oncology, Inc. · 4h agono track record yet
Long 100,000 shares of KURA
Bought 100,000 @ $11.12 avg · $1,112,000 · 2026-08-17

Form 4: WILSON TROY EDWARD bought KURA

WILSON TROY EDWARD (President and CEO at Kura Oncology, Inc.) reported an open-market purchase of 100,000 shares of KURA at an average $11.12, roughly $1,112,000, in a Form 4 filed 2026-08-17.

View filing on SEC.gov →

End of results.